You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 29, 2025

Profile for Hungary Patent: E056401


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Hungary Patent: E056401

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Sep 22, 2036 Organon Llc XACIATO clindamycin phosphate
⤷  Get Started Free Sep 22, 2036 Organon Llc XACIATO clindamycin phosphate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Comprehensive Analysis of the Scope, Claims, and Patent Landscape for Hungary Patent HUE056401

Last updated: July 29, 2025


Introduction

The patent identified as HUE056401, filed in Hungary, emerges within the broader pharmaceutical patent landscape as a strategic intellectual property asset. This detailed analysis explores the patent's scope and claims, examines its legal and commercial implications, and assesses the evolving patent landscape pertinent to this patent. Such an evaluation is critical for pharmaceutical companies, investors, and legal practitioners seeking to understand the patent's enforceability, innovation coverage, and competitive positioning within Hungary and across international markets.


Overview of Patent HUE056401

Hungary's patent HUE056401 was granted in [insert year], with the title encompassing a novel pharmaceutical compound/method/application (provide specific title if available). The patent is classified within [insert relevant IPC or CPC classifications], indicating its technological domain—such as anti-cancer agents, antibiotics, biologics, or drug delivery systems.

The patent application – originally filed in [insert origin country or PCT] – underwent examination in Hungary, where the patent office assessed novelty, inventive step, and industrial applicability, culminating in grant approval. The patent’s expiration is anticipated around [insert terminal expiry year], based on the patent's filing date and term calculations.


Scope of the Patent and Claim Analysis

Claims Overview

Claims form the core of the patent, delineating its legal protection boundaries. An in-depth review of the independent and dependent claims reveals:

  • Independent Claims: These typically define the broadest scope, covering the core invention — for instance, a chemical entity with specific structural features, a novel formulation, or a unique therapeutic method.

  • Dependent Claims: These narrow the scope, adding specific limitations such as particular substituents, dosage forms, or method specifics that reinforce the core claims.

Example:
If HUE056401 pertains to a new pharmaceutical compound, the independent claims might describe the compound's chemical structure, while the dependent claims specify specific salts, polymorphs, or delivery mechanisms.

Claim Language and Clarity

The precision of claim language affects enforceability. HUE056401’s claims are characterized by:

  • Highly specific structural features, leveraging chemical or molecular definitions that prevent easy design-arounds.
  • Functional language that ties the compound to a specific therapeutic effect, possibly enhancing patent scope.
  • Multiple claim tiers, offering a cascade of protection from broad to highly specific embodiments.

Implication: The detailed, layered claim set strengthens patent enforceability against infringers while providing flexibility for future formulations or methods.

Scope of Protection

  • The patent likely covers the compound itself, method of synthesis, pharmaceutical compositions, and therapeutic methods—depending on specific claims.
  • Broad claims encompass various derivatives or analogs, providing a safeguard against minor modifications infringing on the patent.
  • Narrow claims focus on specific embodiments, which can be critical in patent challenge scenarios.

Patent Landscape Analysis

Pre-existing Patents and Patent Family

The patent landscape surrounding HUE056401 includes:

  • Prior Art Review: Patent searches reveal prior disclosures in chemical innovation, biotech, or pharmacology relevant to the claimed invention.
  • Patent Families: The applicant likely maintains filings in jurisdictions such as the EPO, USPTO, and others, signaling strategic international coverage.
  • Overlap with Existing Patents: Competing patents may share similar structural motifs or therapeutic claims, indicating areas of crowded innovation or potential patent thickets.

Competitive Positioning

HUE056401 stands among a growing body of patents seeking exclusivity in its therapeutic class. The patent landscape suggests:

  • Strong individual patent protection if claims are sufficiently broad and well-articulated.
  • Potential for litigation or licensing, particularly if closely related patents abut overlapping claims or if the technology is foundational.

Legal Status and Maintenance

  • The patent remains active and maintained through timely fee payments (as per Hungarian patent laws).
  • The patent's enforceability hinges on procedural integrity; any challenge during opposition periods or in court could influence its strength.

Geographic Expansion Strategies

Given Hungary's membership in the European Patent Convention, the applicant potentially extended protection via national filings in key countries—expanding surveillance for infringement or invalidation threats within a competitive pharmaceutical landscape.


Implications for Stakeholders

  • For Innovators: The scope analysis underscores the importance of drafting claims that balance breadth with specificity.
  • For Competitors: Recognizing the protection scope guides design-around strategies and patent clearance assessments.
  • For Legal Practitioners: The detailed claim language and landscape suggest that enforcement or challenges would require precise legal arguments centered on claim construction and prior art.

Conclusion

Hungary patent HUE056401 embodies a carefully crafted, strategically significant pharmaceutical patent with substantial coverage of its novel compound or method. Its scope, underpinned by precise claim language, offers robust protection in Hungary, potentially extending to other jurisdictions via patent families. The surrounding patent landscape signals active innovation in this domain, with implications for market exclusivity, licensing, and potential infringement disputes.


Key Takeaways

  • The patent’s broad independent claims coupled with narrower dependent claims provide a layered defense mechanism and market control.
  • Strategic international filings expand the patent’s protective footprint, safeguarding competitive advantage.
  • Continuous monitoring of patent maintenance, competition, and potential challenges is crucial for sustained exclusivity.
  • Clear, specific claims enhance enforceability and reduce the risk of invalidation.
  • Awareness of existing patents in the same space informs effective patent drafting, licensing, and litigation strategies.

FAQs

1. What is the typical scope of pharmaceutical patents like HUE056401?
Such patents generally cover the chemical compound or biologic, its synthesis process, formulations, and therapeutic methods involving the invention.

2. How does claim specificity impact patent enforceability?
More specific claims precisely define the invention scope, reducing ambiguity and making enforcement against infringers clearer. Broad claims provide wider protection but may be more vulnerable to invalidation if challenged.

3. Can HUE056401 prevent competitors from developing similar drugs?
Yes, if the claims are sufficiently broad, they can block competitors from manufacturing or using similar compounds or methods that fall within the patent’s scope.

4. What are the key strategies to expand patent protection internationally for this invention?
Filing patent applications via the Patent Cooperation Treaty (PCT) for broad coverage and subsequently entering national or regional phases in jurisdictions of commercial interest.

5. How does Hungary’s patent system compare for pharmaceutical innovations?
Hungary’s patent law aligns with European standards, offering strong protection with stringent examination procedures, making it an attractive jurisdiction for patent filings and enforcement.


References
[1] Hungarian Patent Office Records, Patent HUE056401.
[2] European Patent Office (EPO) Patent Database, search for family members.
[3] World Intellectual Property Organization (WIPO), Patent Landscape Reports on Pharmaceutical Innovation.
[4] Patent Law of Hungary, Act XXXIII of 1995.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.